Evaluation and Characterization of Post-Stroke Lung Damage in a Murine Model of Cerebral Ischemia.
inflammation
pulmonary complications
stroke
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
22 Jul 2022
22 Jul 2022
Historique:
received:
29
06
2022
revised:
19
07
2022
accepted:
19
07
2022
entrez:
28
7
2022
pubmed:
29
7
2022
medline:
30
7
2022
Statut:
epublish
Résumé
After stroke and other brain injuries, there is a high incidence of respiratory complications such as pneumonia or acute lung injury. The molecular mechanisms that drive the brain-lung interaction post-stroke have not yet been elucidated. We performed transient middle cerebral artery occlusion (MCAO) and sham surgery on C57BL/6J mice and collected bronchoalveolar lavage fluid (BALF), serum, brain, and lung homogenate samples 24 h after surgery. A 92 proteins-panel developed by Olink Proteomics® was used to analyze the content in BALF and lung homogenates. MCAO animals had higher protein concentration levels in BALF than sham-controls, but these levels did not correlate with the infarct volume. No alteration in alveolar-capillary barrier permeability was observed. A total of 12 and 14 proteins were differentially expressed between the groups (FDR < 0.1) in BALF and lung tissue homogenates, respectively. Of those, HGF, TGF-α, and CCL2 were identified as the most relevant to this study. Their protein expression patterns were verified by ELISA. This study confirmed that post-stroke lung damage was not associated with increased lung permeability or cerebral ischemia severity. Furthermore, the dysregulation of HGF, TGF-α, and CCL2 in BALF and lung tissue after ischemia could play an important role in the molecular mechanisms underlying stroke-induced lung damage.
Identifiants
pubmed: 35897671
pii: ijms23158093
doi: 10.3390/ijms23158093
pmc: PMC9329771
pii:
doi:
Substances chimiques
Transforming Growth Factor alpha
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI17/02130
Organisme : Instituto de Salud Carlos III
ID : PI21/00939
Organisme : Instituto de Salud Carlos III
ID : RD21/0006/0024
Organisme : Instituto de Salud Carlos III
ID : RD21/0006/0007
Organisme : Instituto de Salud Carlos III
ID : RD21/0006/0015
Organisme : Fundació La Marató de TV3
ID : 201706
Références
Neurocrit Care. 2020 Feb;32(1):272-285
pubmed: 31300956
Stroke. 1986 Nov-Dec;17(6):1304-8
pubmed: 2433817
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Neuropathol Appl Neurobiol. 2012 Oct;38(6):617-27
pubmed: 22289071
Am J Respir Cell Mol Biol. 1994 Nov;11(5):540-51
pubmed: 7524566
Sci Rep. 2019 Mar 6;9(1):3622
pubmed: 30842652
Crit Care. 2018 Oct 5;22(1):249
pubmed: 30290827
Mol Immunol. 2011 Jul;48(12-13):1468-76
pubmed: 21529952
Neurocrit Care. 2009 Dec;11(3):417-26
pubmed: 19548120
J Vis Exp. 2017 May 4;(123):
pubmed: 28518083
Am J Respir Cell Mol Biol. 2002 Apr;26(4):430-7
pubmed: 11919079
Anal Biochem. 1985 Oct;150(1):76-85
pubmed: 3843705
Int J Stroke. 2019 Feb;14(2):125-136
pubmed: 30346258
Crit Care Med. 2000 Jul;28(7):2326-33
pubmed: 10921560
World J Crit Care Med. 2015 Aug 04;4(3):163-78
pubmed: 26261769
Front Immunol. 2020 Oct 15;11:583042
pubmed: 33178214
Acta Neurol Scand. 2018 Oct;138(4):293-300
pubmed: 29749062
Immun Inflamm Dis. 2019 Dec;7(4):326-341
pubmed: 31691533
J Neuroinflammation. 2021 Jun 6;18(1):127
pubmed: 34092245
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Front Neurol. 2018 Jan 19;8:755
pubmed: 29403427
Neurol Res. 1997 Dec;19(6):641-8
pubmed: 9427967
Am J Physiol. 1999 Nov;277(5):L1045-50
pubmed: 10564191
J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3137-3147
pubmed: 30093207
Int J Biochem Cell Biol. 2013 Nov;45(11):2568-73
pubmed: 23988571
Biochemistry. 2003 Feb 25;42(7):2127-36
pubmed: 12590602
Neurotherapeutics. 2022 Mar;19(2):513-527
pubmed: 35226340
Aging (Albany NY). 2016 May;8(5):1049-63
pubmed: 27115295
Acta Pharmacol Sin. 2011 Jan;32(1):12-20
pubmed: 21131996